Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs - an update.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 6
Abstract
Although neuroprotection is effective only against certain aspects of a complex cascade of pathological events during the development and course of epilepsy, it might be a promising option in the treatment of this disease. Some new data on the pathophysiology of epilepsy raised some hopes that the epileptogenesis process can be prevented. A question arises whether it is possible to make the epilepsy develop in a milder, easier to treat and non-progressive way without cognitive decline and drug-resistance. Moreover, once the epilepsy has already been triggered, there is as yet no conclusive evidence that the harmful effects of seizures on the brain can be reduced. So a great deal of further evaluation of antiepileptic drugs (AEDs) is required. Many similarities exist between cerebral ischemia and epilepsy regarding brain-damaging and autoprotective mechanisms that are activated following the injurious insult. Therefore, drugs that are effective in minimizing seizure-induced brain damage may also be useful in minimizing ischemic injury. Most AEDs have been tested in animal models of focal or global ischemia and some were already tested in humans for a possible neuroprotective effect. The existing data are rather scanty and insufficient but it appears that only drugs that have multiple mechanisms of action have some potential in conferring a degree of neuroprotection that could be clinically applicable to stroke patients. In this review, we focus on evidence of neuroprotective properties of novel and potential AEDs, based on animal experimental models of neurodegeneration. In conclusion, some of the newer AEDs show promise as possible neuroprotectants in epilepsy and acute ischemia but more studies are needed before clinical trials in humans could be undertaken.
Authors and Affiliations
Karolina Stępień, Michał Tomaszewski, Stanisław Czuczwar
Keywords
Related Articles
- EP ID EP133835
- DOI -
- Views 119
- Downloads 0
Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction.
Background: We investigated the relationship between withdrawal syndrome symptoms and dopamine receptor 2 DRD2 gene polymorphisms-141 C I/D (rs1799732) exon 8 G/A (rs6276) and ANKK1 (Ankyrin Repeat and Kinase Domain Cont...
Effects of etoricoxib on the pharmacokinetics of phenytoin.
Etoricoxib is presently the most commonly prescribed cyclooxygenase-2 (Cox-2) inhibitor for chronic pain and inflammatory conditions. In clinical practice, phenytoin and etoricoxib are used in chronic conditions of gener...
Mechanisms of [Ca(2+)]i elevation following P2X receptor activation in the guinea-pig small mesenteric artery myocytes.
Background: There is growing evidence suggesting involvement of L-type voltage-gated Ca(2+) channels (VGCCs) in purinergic signaling mechanisms. However, detailed interplay between VGCCs and P2X receptors in intracellula...
Effect of diazepam and chlorpromazine on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial HECa10 cells in vitro.
Diazepam and chlorpromazine - psychotropic agents widely used for the amelioration of anxiety, depression, and psychosis, have been found to affect cell proliferation. We have checked whether these drugs influence prolif...
Oral administration of lithium increases tissue magnesium contents but not plasma magnesium level in rats.
The aim of this work was to determine the influence of different doses of lithium on magnesium concentration in plasma and tissues of rats. For a period of eight weeks rats had been provided with aqueous solutions of Li(...